Table 2 Distribution of life-prolonging treatments among the men over time
1st treatment | 2nd treatment | 3rd treatment | 4th treatment | 5th treatment | Total | |
|---|---|---|---|---|---|---|
Docetaxel | 12 | - | - | - | - | 12 |
Abiraterone | 1 | 1 | - | - | - | 2 |
Enzalutamide | 4 | 5 | - | - | - | 9 |
Radium-223 | - | 1 | - | - | - | 1 |
Cabazitaxel | - | - | 3 | 1 | - | 4 |
N/A; N/K | - | - | - | 2 | 1 | 3 |
Total | 31 |